• The global cryptococcosis treatment market size was valued at USD 5.76 billion in 2025 and is expected to reach USD 10.04 billion by 2033, at a CAGR of 7.20% during the forecast period

• The market growth is largely fueled by the rising prevalence of cryptococcal infections, particularly among immunocompromised populations, including individuals with HIV/AIDS and transplant recipients. Advancements in antifungal therapies, improved diagnostic capabilities, and greater accessibility to healthcare services in developing regions are further accelerating market expansion. Increasing government and NGO-led initiatives aimed at reducing fungal infection–related mortality is also contributing significantly to the growing demand for effective cryptococcosis treatment options

𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -

• Furthermore, growing clinical awareness, rising investment in antifungal drug R&D, and the emergence of new treatment approaches—such as combination antifungal therapy and targeted formulations—are strengthening the adoption of Cryptococcosis Treatment solutions globally. The availability of improved lipid formulations, enhanced hospital infrastructure, and development of next-generation antifungal agents are creating strong momentum in the market, thereby significantly boosting the industry's growth